This paper deals with the area of environmental epidemiology involving measurement of exposure and dose, health outcomes, and important confounding and modifying variables (including genotype and psychosocial factors). Using examples, we illustrate strategies for increasing the accuracy of exposure and dose measurement that include dosimetry algorithms, pharmacokinetic models, biologic markers, and use of multiple measures. Some limitations of these methods are described and suggestions are made about where formal evaluation might be helpful. We go on to discuss methods for assessing the inaccuracies in exposure or dose measurements, including sensitivity analysis and validation studies. In relation to measurement of health outcomes, we discuss some definitional issues and cover, among other topics, biologic effect markers and other early indicators of disease. Because measurement error in covariates is also important, we consider the problems in measurement of common confounders and effect modifiers. Finally, we cite some general methodologic research needs. -Environ Health Perspect 101 (Suppl 4): 49-57 (1993).
Concepts
Environmental exposures can occur as a result of contact with a variety of elements (air, water, soil) that, in turn, influence the pathways for exposure (inhalation, ingestion, dermal). Individuals' interactions with these elements are complex, and therefore it is not surprising that exposure assessment and dose estimation are formidable challenges to those investigating the health effects of environmental agents.
The concepts of exposure and dose have been elaborated in a series of recent publications issued by the Board on Environmental Studies and Toxicology of the National Academy of Sciences (1, 2) . The term exposure refers to the concentration of an agent at the boundary between an individual and the environment as well as the duration ofcontact between the two, but dose refers to the amount actually deposited or absorbed in the body over a given time period. Although internal dose is the ideal measure from the scientific standpoint, regulation can deal only with external exposures, and therefore one may want to measure both exposure and dose.
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Individuals' exposures may be modified by factors such as activity patterns, which determine encounters with various sources of exposure; bioavailability of the agent in time and place; and the rate at which exposure occurs (e.g., a relatively constant rate versus a variable rate). From a given exposure, a person's resultant dose will depend on host characteristics, such as age, sex, and metabolism. It also will reflect the susceptibility of target tissue at the time of exposure; any shielding provided by the body (e.g., the placenta, the blood-brain barrier) or modulation by buildings that attenuate exposure to electric fields and gamma radiation but can be a source of exposure to radon; and the effect of concurrent exposures, such as cigarette smoking or medications. In addition, only partcular components of the dose may be relevant to health effects. For In the past, the methods used to assign exposures in environmental health studies were quite crude, and to some extent they still are (e.g, pesticide usage patterns, residence near a point source of pollution). Even in studies where disease has been ascertained at the individual level, exposure measures may be ecologic in nature and based on average levels for a group. When the group is defined in geographic terms, exposure levels might be estimated from values recorded by environmental sampling in a subject's general vicinity. However, recent research has shown that correlations sometimes are weak between readings from area monitors and subjects' exposures measured using personal monitors (3) , which are presumed to relate more closely to the true dose. Discrepancies between readings from personal and areawide samples can result from heterogeneity of exposures, from poor placement of samplers (e.g., air monitors at elevations well above the breathing zone), or from failure to take account of human activity patterns and other sources of exposure.
sampled (4, 5) . The latter approach is particularly important for ubiquitous compounds like the polycyclic aromatic hydrocarbons. To some extent, personal exposure monitoring is also beginning to be incorporated into environmental health studies. In addition to these attempts to improve externally derived measures of exposure, efforts are being made to estimate internal dose using strategies like empirical dosimetric modeling, pharmacokinetic modeling, and biologic markers.
Such efforts are important. The failure to assign individual exposure and dose accurately leads to measurement errors with consequent effects on measures of association (and, ultimately, risk (11, 12 ) affected a decision not to conduct further research using exposure surrogates based on troop location and herbicide spraying records. These examples underscore the need to be explicit about criteria for acceptable surrogate measures, as well as the need to take error into account when surrogates are used, even while emphasizing the development of better approaches to exposure-dose assessment.
In the following section, we describe methods designed to reduce error in exposure measurement insofar as is currently possible (approaches such as dosimetric modeling, pharmacokinetic modeling, biologic markers, and use of multiple measures), as well as approaches to assessing the residual uncertainties in the estimated dose. Even the best ofthe current methods will not yield a measure that is completely error-free, and it is therefore important to recognize and characterize the residual error in measurement so that it can be considered in analysis ofthe data.
Measurement Approaches Exposu or Dose Modding
Estimating a subject's exposure to an environmental agent involves combining information about possible sources of exposure (usually obtained from the subject, from some other respondent, or from records) with an assessment of the likely degree of exposure from each source.
When an exposure under study is environmental, there may be multiple pathways by which a person might be exposed and it can be important to consider all elements and all routes. For example, residents downwind of the Nevada Test Site could have been exposed to external gamma radiation from the passing fallout cloud itself, from ingesting contaminated milk or vegetables, or, in the case of infants, from in utero exposures or breast-feeding. For each of these pathways, several different radionuclides might need to be considered. After eliminating pathways that would be expected to make a negligible contribution to the total dose, one can estimate the likely dose rate per unit of exposure to each pathway. In the fallout example, this involved consideration of a) source term, the amount and type of radionuclide released; b) the environmental transport, dispersion from the source to sites of deposition; c) rate of radioactive decay and environmental dispersion of the radionudides; d) farm management practices leading to contamination of dairy cattle or vegetables; e) estimates of the uptake of radionudides by vegetables and milk; f) distribution of milk and vegetables to consumers; and g) uptake by the target organ from ingested radionuclides. To calculate an individual's dose, this information was then combined with extensive questionnaire data on breastfeeding and maternal and individual consumption of milk and vegetables at various ages. For some subjects, modifications were needed to allow for homegrown vegetables or backyard cows or goats. For subjects with incomplete exposure information, distributions of default values specific to their particular circumstances (age, sex, location, etc.) were developed. Similar calculations were performed for each of over 100 nudear tests, and the results then were summed to produce estimates of each subject's total dose (13) .
The process described above is far more complex than has been the norm in environmental epidemiology, but it represents the current state of the art in environmental dose assessment. Less refined, but perhaps less costly, approaches to exposure-dose modeling (often for households or geographic areas rather than for individuals) have been based on Gaussian-dispersion modeling of airborne emissions (14) (15) (16) , hydrogeologic modeling of waterborne exposures (17) , and isopleth modeling of soil contaminants (18) . Assuming The EMF example underscores the need for making multiple measures of exposure. In particular, it argues for continuing to indude surrogate measures along with gold standard measures in studies of health effects until the relations between the surrogate and criterion measures are well understood and there is certainty about the true gold standard (i.e., until the correct biologic mechanism is known). Substituting an incorrect gold standard for a surrogate measure can actually increase measurement error. One analytic approach to using multiple measures that has been proposed as a means of increasing validity is to restrict analysis to subjects who are classified as exposed or unexposed by two different, if imperfect, exposure measures (21) . This dearly risks some loss in power since subjects with discordant results on the two measures are excluded from analysis. Another proposed approach is to estimate the misclassification probabilities for each measure and from them to estimate the prevalence of exposure (22) .
Some mention of personal monitors should also be made. While these do not provide a measure of resulting body burden, as biologic markers are meant to do, personal monitors may measure the intensity of an individual's total exposure to airborne agents better than fixed-site area monitors. This is not always the case, however, particularly in studies of long-term exposures or where areawide concentrations are fairly uniform. The TEAM study (TotalExposure Assessment Methodology) conducted by the U.S. Environmental Protection Agency (EPA) found that personal air monitors were acceptable to subjects from 7 to 85 years of age (23) . Investigators studying effects of exposure to EMFs and indoor air pollutants on children are anxious to develop personal monitors that can be used with children under age seven, including toddlers. At present, personal monitors for EMFs are in the form of wristbands and may not be suitable for very young children. Technology for personal exposure monitoring is still evolving, but it will rarely be feasible to apply personal exposure monitoring to all subjects and all relevant time periods. Therefore, methodologic approaches are needed for combining collected exposure data with personal samplers and environmental monitors.
Pharmacokinetic Modeling
Pharmacokinetic modeling is an approach to dosimetry that incorporates information about the internal pharmacologic processes that ensue once an agent reaches the portal(s) of entry into an individual's body (24) . These include uptake into the circulation; distribution within the body; and metabolism, storage, and elimination. These models can be simple, involving only one body compartment, or complex, involving multiple body compartments. In either case, compartmental rate relationships are used in the model's equations to estimate concentrations at critical tissues. Such models are also useful as guides to temporally relevant and efficient ambient sampling (24) . Pharmacokinetic modeling of exposure and dose may be viewed as a counterpart to biologically based disease models.
Biologic Markrs
Because of the difficulty of obtaining accurate and unbiased exposure information from study subjects and the difficulty of estimating the doses that such exposures might produce, there has been great interest in the development of biologic markers. These may be defined as "cellular, biochemical, or molecular alterations that are measurable in biological media, such as human tissue, cells, or fluids" (25) . If used appropriately, biologic markers allow for considerable improvement in measurement of dose. First, they may obviate the errors arising from subjects' lack of knowledge, memory failure, biased recall, or deliberate misinformation (26) . Second, even when subject reports of exposure are accurate, individuals may vary considerably in uptake and handling of a material; the error introduced by such individual variation can be reduced or removed by using markers that provide an estimate of the dose to a particular individual. Third, some markers can be used to detect biological interactions between the exposure of interest and critical tissues; DNA adducts are an example of this type of marker. In studying environmental tobacco smoke, for instance, one can-in addition to asking about maternal smoking during pregnancy-actually measure smokingrelated DNA adducts in placentae (27) and, where the fetus is lost, in critical organs such as fetal lung or liver (28 in the cohort of atomic bomb survivors, it has been reported that subjects with a history of epilation have a 2.5-fold steeper dose-response curve for leukemia than those without (29) . This can be interpreted either as an indicator of their greater radiosensitivity or as an indicator of misestimation of their doses, perhaps as a result of differences in shielding not accounted for by available dosimetry data.
To be useful in environmental epidemiology studies, a biologic exposure marker should be dearly better than anamnestic data or environmental measures; should allow for differentiation between exposure levels; should be applicable on a large scale; or if too costly for large-scale use, should at least be acceptable to subjects in a validation substudy. Before markers are used in epidemiologic research, their sensitivity and specificity should be known from both the laboratory and epidemiologic perspectives; reproducibility of results within and between laboratories must also be known; and, very importantly, the particular time frame they reflect and during which they can be measured in vivo must be established (25) Doll (47) and by Davis et al. (48) about cancer time trends. It might be helpful to have a set of recommended approaches for trend analysis that were developed by a group of dispassionate methodologists. For etiologic studies, incidence data seem conceptually superior; when mortality data are used, consideration needs to be given to accounting for influences on survival since these might correlate with exposure.
In some areas of research, such as reproduction and development, different outcomes can occur depending on the timing and dose of exposure. In such circumstances, it may be important to examine several end points. Extending populationbased registration systems to cover more outcomes than cancer and birth defects and to cover more geographic areas potentially could be useful for environmental studies in several respects: in identification of cases, in validation of self-reported information, and in ascertaining disease status of migrants.
Biologic Effect Markers and Other
Early Indicators ofDiseaw Biologic effect markers potentially have a number of advantages as study end points, particularly if they are strongly prognostic of disease in ways not explained by available exposure information-for example, by reflecting susceptibility or the action of cofactors (26) . While some effect markers are actually subclinical events (e.g., biochemical tests of occult pregnancy loss), often markers of effect correlate only weakly with disease. Serum alpha-fetoprotein is a useful marker for liver cancer as well as a prenatal marker for neural tube defects. Markers that are not as clearly predictive of risk, particularly at the individual level, can lead to problems of interpretation and to needless anxiety for those individuals found to have elevated levels. The premature application of a poorly standardized cytological assay on a group of already concerned residents at Love Canal is a case in point. Calls have been made repeatedly to carry out longitudinal studies, in experimental animals and humans, that will measure the positive predictive value of such markers before applying them in field studies; but these have been largely ignored. The Scandinavian countries, however, have mounted a collaborative prospective study of cancer in a cohort of 3190 individuals who have been tested for sister chromatid exchanges (SCEs), structural chromosome aberrations, or both. A report based on a 13-year follow up of 800 subjects in the Finnish portion of the data (49) (51, 52) . Methodologic needs in the area of effect markers include attention to sources of variability, both biological and laboratory-related, and to logistical issues, such as how to achieve reasonable participation rates when the effect marker requires a demanding regimen. Three current studies of early pregnancy loss illustrate this latter problem. Two of the studies ask participants for daily urine samples. The third study uses a modified specimen collection scheme requiring urine samples only twice monthly, at the beginning of menses. Preliminary data indicate higher response rates for the study with the simplified collection protocol. Whether the variability in enrollment is due to the differing demands on study subjects or to other variable aspects of the three studies (such as the perceived salience of the topic in the target population) is not known. Systematic research is needed to determine how to achieve cooperation in studies that use biologic markers and how to provide for calculating or estimating the extent and magnitude of selection bias. A second important aspect of methodologic research relates to sensitivity analyses and other approaches for estimating the uncertainty in measurement of exposure and dose. Included in this category would be validation studies to compare a gold standard with a more error-prone exposure measurement in order to allow for correction of bias in the analysis stage of research. Consideration needs to be given to the costs and benefits of investigating measurement error in the primary study or in a substudy (which could be carried out intemally or extemally in relation to the primary study). A final area that deserves attention is measurement error in covariates, which can be as important as measurement error in the exposure or outcome variables. eg
